Ledger.Open graph →
SEC Form D · filed December 26, 2018

Entrada Therapeutics, Inc

Offering
$59.0M
Sold
$34.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Natarajan Sethuraman · Boston, MAExecManager of the General Partner CrossHarbor Capital Partners LLC · Boston, MAExecKush Parmar · Boston, MADirectorDipal Doshi · Boston, MAExec · DirectorAnja Harmeier · Watertown, MADirectorLouis Tartaglia · Boston, MADirectorDehua Pei · Boston, MADirectorChristopher Kemp · Seatttle, WAExecKush Parmar · San Francisco, CADirectorDipal Doshi · Boston, MAExec · DirectorAnja Harmeier · Watertown, MADirectorLouis Tartaglia · San Francisco, CADirectorDehua Pei · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗